ProMIS Neurosciences, Inc.
PMN
$0.52
$0.0193.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 93.35% | 492.94% | -13.48% | 26.70% | 50.72% |
| Total Depreciation and Amortization | -- | -- | -- | -- | 1,025.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,668.56% | -17,287.50% | 91.97% | -54.08% | 83.36% |
| Change in Net Operating Assets | -19,367.76% | -4,379.54% | 71.81% | -402.38% | -100.48% |
| Cash from Operations | -131.89% | -180.71% | 29.94% | -301.74% | 17.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.15% | -- | -- | -- | -- |
| Cash from Investing | 46.15% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 49.05% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 192.05% | 49.05% | -- | -- | -107.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -93.10% | 31.31% | 28.67% | -297.06% | -318.41% |